1.
Ann Cardiol Angeiol (Paris)
; 52(3): 191-3, 2003 Jun.
Artigo
em Francês
| MEDLINE
| ID: mdl-12938574
RESUMO
We report our experience with a case of isolated profound thrombocytopenia after clopidogrel (thienopyridine) administration. No adverse event such as bleeding or thrombotic event had occurred, although clopidogrel has been discontinued two weeks after the coronary artery stenting. Despite the safety of clopidogrel, this case demonstrates that clopidogrel can be associated not only with thrombotic thrombocytopenic purpura but also with isolated thrombocytopenia.